Cell
Volume 79, Issue 2, 21 October 1994, Pages 315-328
ArticleAngiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
References (77)
- et al.
Cell death and control of cell survival in the oligodendrocyte lineage
Cell
(1992) Autoregulation of ascites tumor growth by inhibition of the G-1 and the G-2 phase
Eur. J. Cancer
(1971)Concomitant tumor immunity and the resistance to a second tumor challenge
Adv. Cancer Res.
(1983)- et al.
Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane
Microvascular Res.
(1994) - et al.
Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene
Cell
(1989) - et al.
Inhibition of DNA synthesis by a factor from ascites tumor cells
Eur. J. Cancer
(1977) - et al.
A plasminogen-related gene is expressed in cancer cells
Biochem. Biophys. Res. Commun.
(1992) - et al.
The natural and induced resistance of mice to the growth of cancer
- et al.
Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-Sepharose, and fibrin cleaved by plasmin
Biochemistry
(1985) - et al.
Role of concomitant resistance in the development of murine lung metastases
Int. J. Cancer
(1988)
Clinical experiments by homotransplants, autotransplants and admixture of autologous leucocytes
Ann. Surgery
(1965)
Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats
Carcinogenesis
(1990)
Antisense-mediated reduction in thrombospondin reverses the malignant phenotype of a human squamous carcinoma
J. Clin. Invest.
(1991)
The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis
Endocrinology
(1993)
Model predicting survival in stage I melanoma based on tumor progression
J. Natl. Cancer Inst.
(1989)
Plasminogen: purification from human plasma by affinity chromatography
Science
(1970)
Studies correlating the growth rate of a tumor and its metastases and providing evidence for tumor-related systemic growth-retarding factors
Cancer Res.
(1972)
Beobachtungen über maligne Mäusetumoren
Berl. klin. Wschr.
(1905)
Suppressive factors in ascitic fluids and sera of mice bearing ascites tumors
J. Natl. Cancer Inst.
(1977)
Cancer metastasis
Br. Med. Bull.
(1991)
Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases
Cancer Res.
(1983)
Presence of a growth-stimulating factor in serum following primary tumor removal in mice
Cancer Res.
(1989)
Tumor angiogenesis: therapeutic implications
N. Engl. J. Med.
(1971)
What is the evidence that tumors are angiogenesis dependent?
J. Natl. Cancer Inst.
(1989)
Angiogenesis and breast cancer
J. Clin. Oncol.
(1994)
Long-term culture of capillary endothelial cells
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
J. Cell Biol.
(1992)
On concomitant immunity in tumor-bearing hamsters
Nature
(1967)
A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin
Resistance of tumor-bearing mice to a second tumor challenge
Cancer Res.
(1983)
Growth of a local tumor exerts a specific inhibitory effect on progression of lung metastases
Int. J. Cancer.
(1978)
Control of lung metastasis progression in mice: role of growth kinetics of 3LL Lewis lung carcinoma and host immune reactivity
J. Natl. Cancer Inst.
(1980)
On the mechanism of tumor “concomitant immunity”
Int. J. Cancer
(1981)
The inhibitory influence of a transplanted hamster lymphoma on metastasis
Cancer Res.
(1960)
Effect of surgical removal on the growth and kinetics of residual tumor
Cancer Res.
(1979)
Inhibition of Lewis lung tumor growth and metastasis by Ehrlich ascites tumor growing in the same host
J. Cancer Res. Clin. Oncol.
(1986)
Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth
Am. J. Pathol.
(1985)
Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor
Cancer Res.
(1991)
Cited by (0)
Copyright © 1994